366 related articles for article (PubMed ID: 35887337)
21. Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future.
Oliveira ECS; Quaglio AEV; Magro DO; Di Stasi LC; Sassaki LY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108339
[TBL] [Abstract][Full Text] [Related]
22. Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease.
Elamir A; Shaker O; Kamal M; Khalefa A; Abdelwahed M; Abd El Reheem F; Ahmed T; Hassan E; Ayoub S
PLoS One; 2022; 17(10):e0275267. PubMed ID: 36206229
[TBL] [Abstract][Full Text] [Related]
23. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
24. Differential Gene Expression Profiles Involved in the Inflammations Due to COVID-19 and Inflammatory Bowel Diseases and the Investigation of Predictive Biomarkers.
Aishwarya S; Gunasekaran K
Biochem Genet; 2024 Feb; 62(1):311-332. PubMed ID: 37335372
[TBL] [Abstract][Full Text] [Related]
25. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.
Wu F; Guo NJ; Tian H; Marohn M; Gearhart S; Bayless TM; Brant SR; Kwon JH
Inflamm Bowel Dis; 2011 Jan; 17(1):241-50. PubMed ID: 20812331
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatic analysis of potential candidates for therapy of inflammatory bowel disease.
Li XL; Zhou CY; Sun Y; Su ZY; Wang X; N Jia E; Zhang Q; Jiang XF; Qi WQ; Xu Y
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(22):4275-84. PubMed ID: 26636514
[TBL] [Abstract][Full Text] [Related]
27. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.
Lin J; Welker NC; Zhao Z; Li Y; Zhang J; Reuss SA; Zhang X; Lee H; Liu Y; Bronner MP
Mod Pathol; 2014 Apr; 27(4):602-8. PubMed ID: 24051693
[TBL] [Abstract][Full Text] [Related]
28. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients.
Atanassova A; Georgieva A
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6310-6315. PubMed ID: 36111932
[TBL] [Abstract][Full Text] [Related]
29. Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach.
Stemmer E; Zahavi T; Kellerman M; Sinberger LA; Shrem G; Salmon-Divon M
Front Immunol; 2024; 15():1353402. PubMed ID: 38510241
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis.
Sun L; Han Y; Wang H; Liu H; Liu S; Yang H; Ren X; Fang Y
J Int Med Res; 2022 Apr; 50(4):3000605221089503. PubMed ID: 35443818
[TBL] [Abstract][Full Text] [Related]
31. LINC00641/miR-378a and Their Cross-Talk with TNF-α/IFN-γ as Potential Biomarkers in Ulcerative Colitis and Crohn's Diseases.
Hameed NAA; Shaker OG; Hasona NA
J Interferon Cytokine Res; 2023 Nov; 43(11):531-537. PubMed ID: 37956249
[TBL] [Abstract][Full Text] [Related]
32. Integrating analysis reveals microRNA-mediated pathway crosstalk among Crohn's disease, ulcerative colitis and colorectal cancer.
Bai J; Li Y; Shao T; Zhao Z; Wang Y; Wu A; Chen H; Li S; Jiang C; Xu J; Li X
Mol Biosyst; 2014 Jul; 10(9):2317-28. PubMed ID: 24949825
[TBL] [Abstract][Full Text] [Related]
33. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis.
Ludwig K; Fassan M; Mescoli C; Pizzi M; Balistreri M; Albertoni L; Pucciarelli S; Scarpa M; Sturniolo GC; Angriman I; Rugge M
Virchows Arch; 2013 Jan; 462(1):57-63. PubMed ID: 23224068
[TBL] [Abstract][Full Text] [Related]
34. Prognosticating the Course of Inflammatory Bowel Disease.
Koliani-Pace JL; Siegel CA
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):395-404. PubMed ID: 31078243
[TBL] [Abstract][Full Text] [Related]
35. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.
Shaker OG; Safa A; Khairy A; Abozeid NF
Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920
[TBL] [Abstract][Full Text] [Related]
36. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease in India - Past, present and future.
Ray G
World J Gastroenterol; 2016 Sep; 22(36):8123-36. PubMed ID: 27688654
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.
Bennike T; Birkelund S; Stensballe A; Andersen V
World J Gastroenterol; 2014 Mar; 20(12):3231-44. PubMed ID: 24696607
[TBL] [Abstract][Full Text] [Related]
39. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
Chung-Faye G; Hayee B; Maestranzi S; Donaldson N; Forgacs I; Sherwood R
Inflamm Bowel Dis; 2007 Nov; 13(11):1374-8. PubMed ID: 17577247
[TBL] [Abstract][Full Text] [Related]
40. Screening of hub inflammatory bowel disease biomarkers and identification of immune-related functions based on basement membrane genes.
Lin P; Hua J; Teng Z; Lin C; Liu S; He R; Chen H; Yao H; Ye J; Zhu G
Eur J Med Res; 2023 Jul; 28(1):247. PubMed ID: 37481583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
